UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Sovereign Financial Group Inc.

Sovereign Financial Group Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 6.3% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 2,078 shares of the healthcare conglomerate’s stock after buying an additional 124 shares during the period. Sovereign Financial Group Inc.’s holdings in UnitedHealth Group were worth $1,094,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of UNH. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the 4th quarter valued at about $26,000. CGC Financial Services LLC boosted its stake in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC raised its stake in shares of UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares in the last quarter. LFA Lugano Financial Advisors SA increased its holdings in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the last quarter. Finally, Annapolis Financial Services LLC grew its position in shares of UnitedHealth Group by 38.6% in the 3rd quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock worth $40,000 after acquiring an additional 22 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

UNH stock traded up $2.25 during mid-day trading on Wednesday, reaching $503.21. 2,942,890 shares of the stock traded hands, compared to its average volume of 4,361,874. The firm has a market capitalization of $462.99 billion, a PE ratio of 30.62, a P/E/G ratio of 1.43 and a beta of 0.55. The business has a 50-day moving average of $481.45 and a two-hundred day moving average of $511.98. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the company posted $6.26 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Barclays lifted their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Piper Sandler lifted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target on the stock in a research report on Thursday, April 4th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

View Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.